Pipeline Peak 4: GI Restricted ROCK Inhibitor RXC008 for The Treatment of Fibrotic Strictures in Crohn’s Disease

Time: 9:40 am
day: Day Two


  • Strictures have no current pharmaceutical treatment
  • RXC008 is a potent anti-fibrotic that has the promise to be one of the first effective therapies to reverse stricture formation
  • RXC008 may also protect GI tissues from inflammatory injury and enhance mucosal healing